SPC312
Gívósíran eða lyfjafræðilega viðunandi salt þar af
Status:
VeittApplication date:
26.8.2020Application published:
15.9.2020Grant published:
15.11.2022
Max expiry date:
3.3.2035Medicine name:
GivlaariMedicine for children:
No
Timeline
Today
26.8.2020Application
15.9.2020Publication
15.11.2022Registration
3.3.2035Expires
Marketing license
IS authorization number:
EU/1/20/1428/001Date:
20.3.2020
Foreign authorization number:
EU/1/20/1428Date:
2.3.2020
Owner
Name:
Alnylam Pharmaceuticals, Inc.Address:
300 Third Street, Cambridge, MA 02142 US
Name:
Icahn School of Medicine at Mount SinaiAddress:
One Gustave L. Levy Place, New York, NY 10029 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3052628